Francesco Rodeghiero
Papers
1
Total Citations
30
H-Index
1
About
Francesco Rodeghiero is a leading hematologist whose research has fundamentally advanced the diagnosis and management of von Willebrand disease (VWD), the most common inherited bleeding disorder. His key contributions center on refining diagnostic criteria, particularly for type 1 VWD, and developing practical laboratory tools to improve clinical accuracy. In a landmark European multicenter study (MCMDM-1VWD), Rodeghiero validated a rapid, automated immunoassay (VWF-LIA) for quantifying von Willebrand factor antigen, demonstrating its high sensitivity and specificity in distinguishing patients with type 1 VWD from healthy individuals. This work, cited over 30 times, provided a reproducible, cost-effective alternative to traditional methods, directly influencing international guidelines. Beyond this, his broader research has shaped the understanding of bleeding assessment tools and the natural history of VWD, earning him recognition as a pioneer in hemostasis. With a career spanning decades and hundreds of publications, Rodeghiero’s legacy lies in translating complex pathophysiology into accessible, evidence-based diagnostics that empower clinicians worldwide—a testament to his enduring impact on patient care.
Research Focus
Key Achievements
Top Papers
- 1